Attached files
| file | filename |
|---|---|
| EX-32 - EX-32.1 - Cortexyme, Inc. | crtx-ex32_24.htm |
| EX-31 - EX-31.2 - Cortexyme, Inc. | crtx-ex31_27.htm |
| EX-31 - EX-31.1 - Cortexyme, Inc. | crtx-ex31_26.htm |
| EX-23.1 - EX-23.1 - Cortexyme, Inc. | crtx-ex231_465.htm |
| EX-4.3 - EX-4.3 - Cortexyme, Inc. | crtx-ex43_369.htm |
| 10-K - 10-K - Cortexyme, Inc. | crtx-10k_20191231.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Cortexyme, Inc. (the “Company”) on Form 10-K for the period ended December 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
|
|
(1) |
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 as amended; and |
|
|
(2) |
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
|
Date: March 16, 2020 |
|
By: |
/s/ Christopher Lowe |
|
|
|
|
Christopher Lowe |
|
|
|
|
Chief Financial Officer (Principal Financial and Accounting Officer) |